Galaxy Therapeutics
Milpitas, US · Founded 2020 · Delaware corporation
Galaxy Therapeutics is a clinical-phase medical device company developing the SEAL Embolization Device, an intrasaccular flow diversion implant for treating brain aneurysms. Its products target neurointerventional physicians and are progressing through FDA PMA and European CE Mark regulatory pathways.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$13M disclosed across 4 rounds · 2020–2022
▶$7.6MraisedJul 2024 · 50 investors · Other Health CareRule 506(b)
▶$7.6MraisedJul 2024 · 50 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Osama ZaidatExecutive Officer, Director
- Amount sold
- $7.6M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2.1MraisedJul 2024 · 26 investors · Other Health CareRule 506(b)
▶$2.1MraisedJul 2024 · 26 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Osama ZaidatExecutive Officer, Director
- Amount sold
- $2.1M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$3MraisedJul 2024 · 47 investors · Other Health CareRule 506(b)
▶$3MraisedJul 2024 · 47 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Osama ZaidatExecutive Officer, Director
- Amount sold
- $3M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$325KraisedFeb 2020 · 3 investors · Other Health CareRule 506(b)
▶$325KraisedFeb 2020 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- OSAMA ZAIDATExecutive Officer, Director
- AAMIR BADRUDDINExecutive Officer, Director
- EDGARD PEREIRAExecutive Officer, Director
- THOMAS WOLFEExecutive Officer, Director
- Amount sold
- $325K
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapRead the Press Release7 shared keywordsStryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers. It operates globally across the Americas, Europe, Asia-Pacific, and the Middle East.
Rf Surgical5 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Companies competing with Galaxy Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Galaxy Therapeutics do?
- Galaxy Therapeutics is a clinical-phase medical device company developing the SEAL Embolization Device, an intrasaccular flow diversion implant for treating brain aneurysms. Its products target neurointerventional physicians and are progressing through FDA PMA and European CE Mark regulatory pathways.
- How much funding has Galaxy Therapeutics raised?
- Galaxy Therapeutics has disclosed $13M raised across 4 rounds.
- Where is Galaxy Therapeutics headquartered?
- Galaxy Therapeutics is headquartered in Milpitas, US.